Co-Microencapsulation of Islets and MSC CellSaics, Mosaic-Like Aggregates of MSCs and Recombinant Peptide Pieces, and Therapeutic Effects of Their Subcutaneous Transplantation on Diabetes
The subcutaneous transplantation of microencapsulated islets has been extensively studied as a therapeutic approach for type I diabetes. However, due to the lower vascular density and strong inflammatory response in the subcutaneous area, there have been few reports of successfully normalized blood...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-08-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/8/9/318 |
| _version_ | 1797555069304963072 |
|---|---|
| author | Yusuke Mochizuki Ryo Kogawa Ryuta Takegami Kentaro Nakamura Akira Wakabayashi Tadashi Ito Yasuhiro Yoshioka |
| author_facet | Yusuke Mochizuki Ryo Kogawa Ryuta Takegami Kentaro Nakamura Akira Wakabayashi Tadashi Ito Yasuhiro Yoshioka |
| author_sort | Yusuke Mochizuki |
| collection | DOAJ |
| description | The subcutaneous transplantation of microencapsulated islets has been extensively studied as a therapeutic approach for type I diabetes. However, due to the lower vascular density and strong inflammatory response in the subcutaneous area, there have been few reports of successfully normalized blood glucose levels. To address this issue, we developed mosaic-like aggregates comprised of mesenchymal stem cells (MSCs) and recombinant peptide pieces called MSC CellSaics, which provide a continuous release of angiogenic factors and anti-inflammatory cytokines. Our previous report revealed that the diabetes of immunodeficient diabetic model mice was reversed by the subcutaneous co-transplantation of the MSC CellSaics and rat islets. In this study, we focused on the development of immune-isolating microcapsules to co-encapsulate the MSC CellSaics and rat islets, and their therapeutic efficiency via subcutaneous transplantation into immunocompetent diabetic model mice. As blood glucose level was monitored for 28 days following transplantation, the normalization rate of the new immuno-isolating microcapsules was confirmed to be significantly higher than those of the microcapsules without the MSC CellSaics, and the MSC CellSaics transplanted outside the microcapsules (<i>p</i> < 0.01). Furthermore, the number of islets required for the treatment was reduced. In the stained sections, a larger number/area of blood vessels was observed around the new immuno-isolating microcapsules, which suggests that angiogenic factors secreted by the MSC CellSaics through the microcapsules function locally for their enhanced efficacy. |
| first_indexed | 2024-03-10T16:41:02Z |
| format | Article |
| id | doaj.art-ac07c45cadb749b1a73bf80bb8386543 |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-10T16:41:02Z |
| publishDate | 2020-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-ac07c45cadb749b1a73bf80bb83865432023-11-20T12:01:14ZengMDPI AGBiomedicines2227-90592020-08-018931810.3390/biomedicines8090318Co-Microencapsulation of Islets and MSC CellSaics, Mosaic-Like Aggregates of MSCs and Recombinant Peptide Pieces, and Therapeutic Effects of Their Subcutaneous Transplantation on DiabetesYusuke Mochizuki0Ryo Kogawa1Ryuta Takegami2Kentaro Nakamura3Akira Wakabayashi4Tadashi Ito5Yasuhiro Yoshioka6Bioscience and Bioengineering Laboratory, Research and Development Headquarters, FUJIFILM Corporation, Kanagawa 258-8577, JapanBioscience and Bioengineering Laboratory, Research and Development Headquarters, FUJIFILM Corporation, Kanagawa 258-8577, JapanBioscience and Bioengineering Laboratory, Research and Development Headquarters, FUJIFILM Corporation, Kanagawa 258-8577, JapanBioscience and Bioengineering Laboratory, Research and Development Headquarters, FUJIFILM Corporation, Kanagawa 258-8577, JapanBioscience and Bioengineering Laboratory, Research and Development Headquarters, FUJIFILM Corporation, Kanagawa 258-8577, JapanBioscience and Bioengineering Laboratory, Research and Development Headquarters, FUJIFILM Corporation, Kanagawa 258-8577, JapanBioscience and Bioengineering Laboratory, Research and Development Headquarters, FUJIFILM Corporation, Kanagawa 258-8577, JapanThe subcutaneous transplantation of microencapsulated islets has been extensively studied as a therapeutic approach for type I diabetes. However, due to the lower vascular density and strong inflammatory response in the subcutaneous area, there have been few reports of successfully normalized blood glucose levels. To address this issue, we developed mosaic-like aggregates comprised of mesenchymal stem cells (MSCs) and recombinant peptide pieces called MSC CellSaics, which provide a continuous release of angiogenic factors and anti-inflammatory cytokines. Our previous report revealed that the diabetes of immunodeficient diabetic model mice was reversed by the subcutaneous co-transplantation of the MSC CellSaics and rat islets. In this study, we focused on the development of immune-isolating microcapsules to co-encapsulate the MSC CellSaics and rat islets, and their therapeutic efficiency via subcutaneous transplantation into immunocompetent diabetic model mice. As blood glucose level was monitored for 28 days following transplantation, the normalization rate of the new immuno-isolating microcapsules was confirmed to be significantly higher than those of the microcapsules without the MSC CellSaics, and the MSC CellSaics transplanted outside the microcapsules (<i>p</i> < 0.01). Furthermore, the number of islets required for the treatment was reduced. In the stained sections, a larger number/area of blood vessels was observed around the new immuno-isolating microcapsules, which suggests that angiogenic factors secreted by the MSC CellSaics through the microcapsules function locally for their enhanced efficacy.https://www.mdpi.com/2227-9059/8/9/318CellSaicADSCmicroencapsulationxenotransplantationisletsubcutaneous |
| spellingShingle | Yusuke Mochizuki Ryo Kogawa Ryuta Takegami Kentaro Nakamura Akira Wakabayashi Tadashi Ito Yasuhiro Yoshioka Co-Microencapsulation of Islets and MSC CellSaics, Mosaic-Like Aggregates of MSCs and Recombinant Peptide Pieces, and Therapeutic Effects of Their Subcutaneous Transplantation on Diabetes Biomedicines CellSaic ADSC microencapsulation xenotransplantation islet subcutaneous |
| title | Co-Microencapsulation of Islets and MSC CellSaics, Mosaic-Like Aggregates of MSCs and Recombinant Peptide Pieces, and Therapeutic Effects of Their Subcutaneous Transplantation on Diabetes |
| title_full | Co-Microencapsulation of Islets and MSC CellSaics, Mosaic-Like Aggregates of MSCs and Recombinant Peptide Pieces, and Therapeutic Effects of Their Subcutaneous Transplantation on Diabetes |
| title_fullStr | Co-Microencapsulation of Islets and MSC CellSaics, Mosaic-Like Aggregates of MSCs and Recombinant Peptide Pieces, and Therapeutic Effects of Their Subcutaneous Transplantation on Diabetes |
| title_full_unstemmed | Co-Microencapsulation of Islets and MSC CellSaics, Mosaic-Like Aggregates of MSCs and Recombinant Peptide Pieces, and Therapeutic Effects of Their Subcutaneous Transplantation on Diabetes |
| title_short | Co-Microencapsulation of Islets and MSC CellSaics, Mosaic-Like Aggregates of MSCs and Recombinant Peptide Pieces, and Therapeutic Effects of Their Subcutaneous Transplantation on Diabetes |
| title_sort | co microencapsulation of islets and msc cellsaics mosaic like aggregates of mscs and recombinant peptide pieces and therapeutic effects of their subcutaneous transplantation on diabetes |
| topic | CellSaic ADSC microencapsulation xenotransplantation islet subcutaneous |
| url | https://www.mdpi.com/2227-9059/8/9/318 |
| work_keys_str_mv | AT yusukemochizuki comicroencapsulationofisletsandmsccellsaicsmosaiclikeaggregatesofmscsandrecombinantpeptidepiecesandtherapeuticeffectsoftheirsubcutaneoustransplantationondiabetes AT ryokogawa comicroencapsulationofisletsandmsccellsaicsmosaiclikeaggregatesofmscsandrecombinantpeptidepiecesandtherapeuticeffectsoftheirsubcutaneoustransplantationondiabetes AT ryutatakegami comicroencapsulationofisletsandmsccellsaicsmosaiclikeaggregatesofmscsandrecombinantpeptidepiecesandtherapeuticeffectsoftheirsubcutaneoustransplantationondiabetes AT kentaronakamura comicroencapsulationofisletsandmsccellsaicsmosaiclikeaggregatesofmscsandrecombinantpeptidepiecesandtherapeuticeffectsoftheirsubcutaneoustransplantationondiabetes AT akirawakabayashi comicroencapsulationofisletsandmsccellsaicsmosaiclikeaggregatesofmscsandrecombinantpeptidepiecesandtherapeuticeffectsoftheirsubcutaneoustransplantationondiabetes AT tadashiito comicroencapsulationofisletsandmsccellsaicsmosaiclikeaggregatesofmscsandrecombinantpeptidepiecesandtherapeuticeffectsoftheirsubcutaneoustransplantationondiabetes AT yasuhiroyoshioka comicroencapsulationofisletsandmsccellsaicsmosaiclikeaggregatesofmscsandrecombinantpeptidepiecesandtherapeuticeffectsoftheirsubcutaneoustransplantationondiabetes |